Viewing Study NCT06479759


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT06479759
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module